Sui G - Search Results

1

Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.

Guo F, Fu Q, Wang Y, Sui G. Guo F, et al. Among authors: sui g. J Cell Mol Med. 2019 Sep;23(9):5907-5919. doi: 10.1111/jcmm.14386. Epub 2019 Jul 14. J Cell Mol Med. 2019. PMID: 31304680 Free PMC article.

2

Value of ultrasound elastography in assessment of enlarged cervical lymph nodes.

Teng DK, Wang H, Lin YQ, Sui GQ, Guo F, Sun LN. Teng DK, et al. Asian Pac J Cancer Prev. 2012;13(5):2081-5. doi: 10.7314/apjcp.2012.13.5.2081. Asian Pac J Cancer Prev. 2012. PMID: 22901174 Free article.

3

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

Sui GQ, Fei D, Guo F, Zhen X, Luo Q, Yin S, Wang H. Sui GQ, et al. Am J Cancer Res. 2017 May 1;7(5):1177-1187. eCollection 2017. Am J Cancer Res. 2017. PMID: 28560065 Free PMC article.

4

Anticancer effect of YWHAZ silencing via inducing apoptosis and autophagy in gastric cancer cells.

Guo F, Jiao D, Sui GQ, Sun LN, Gao YJ, Fu QF, Jin CX. Guo F, et al. Among authors: sui gq. Neoplasma. 2018 Sep 19;65(5):693-700. doi: 10.4149/neo_2018_170922N603. Epub 2018 Jun 17. Neoplasma. 2018. PMID: 29940752

5

miR-375-3p/YWHAZ/β-catenin axis regulates migration, invasion, EMT in gastric cancer cells.

Guo F, Gao Y, Sui G, Jiao D, Sun L, Fu Q, Jin C. Guo F, et al. Among authors: sui g. Clin Exp Pharmacol Physiol. 2019 Feb;46(2):144-152. doi: 10.1111/1440-1681.13047. Epub 2018 Dec 21. Clin Exp Pharmacol Physiol. 2019. PMID: 30353914

6

Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma.

Wang Y , Sui G , Teng D , Wang Q , Qu J , Zhu L , Ran H , Wang Z , Jin C , Wang H . Wang Y , et al. Among authors: sui g. Biomater Sci. 2018 Dec 18;7(1):196-210. doi: 10.1039/c8bm00970h. Biomater Sci. 2018. PMID: 30422139

7

The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206.

Fei D, Sui G, Lu Y, Tan L, Dongxu Z, Zhang K. Fei D, et al. Among authors: sui g. J Cell Mol Med. 2019 Mar;23(3):1865-1872. doi: 10.1111/jcmm.14087. Epub 2018 Dec 19. J Cell Mol Med. 2019. Retraction in: J Cell Mol Med. 2024 Mar;28(6):e18199. doi: 10.1111/jcmm.18199. PMID: 30565392 Free PMC article. Retracted.

8

The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.

Sui G, Zhang B, Fei D, Wang H, Guo F, Luo Q. Sui G, et al. J Cell Physiol. 2020 Oct;235(10):6615-6624. doi: 10.1002/jcp.29557. Epub 2020 Feb 11. J Cell Physiol. 2020. Retraction in: J Cell Physiol. 2022 Apr;237(4):2293. doi: 10.1002/jcp.30618. PMID: 32048306 Retracted.

9

A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.

Qu J , Teng D , Sui G , Guan S , Wang Y , Wang Q , Lin Y , Ran H , Wang Z , Wang H . Qu J , et al. Among authors: sui g. Biomater Sci. 2020 Jun 7;8(11):3116-3129. doi: 10.1039/d0bm00003e. Epub 2020 Apr 30. Biomater Sci. 2020. PMID: 32352102

10

hsa_circ_0001018 promotes papillary thyroid cancer by facilitating cell survival, invasion, G₁/S cell cycle progression, and repressing cell apoptosis via crosstalk with miR-338-3p and SOX4.

Luo Q, Guo F, Fu Q, Sui G. Luo Q, et al. Among authors: sui g. Mol Ther Nucleic Acids. 2021 Feb 24;24:591-609. doi: 10.1016/j.omtn.2021.02.023. eCollection 2021 Jun 4. Mol Ther Nucleic Acids. 2021. PMID: 33898108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters